Dasanat 50® Dasatinib Tablets

Dasanat 50 mg contains dasatinib and is used to treat specific types of leukaemia, including CML and Ph+ ALL. It inhibits abnormal tyrosine kinase activity associated with these cancers, helping slow or stop the growth of malignant cells in the bone marrow

As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.

Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.

Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.

Store below 30 °C in a dry place, in the original pack, out of reach of children.